Molybdenum Cofactor Deficiency: Mega Cisterna Magna in Two Consecutive Pregnancies and Review of the Literature.

The Application of Clinical Genetics Pub Date : 2020-01-30 eCollection Date: 2020-01-01 DOI:10.2147/TACG.S239917
M C Alonzo Martínez, E Cazorla, E Cánovas, K Anniuk, A E Cores, A M Serrano
{"title":"Molybdenum Cofactor Deficiency: Mega Cisterna Magna in Two Consecutive Pregnancies and Review of the Literature.","authors":"M C Alonzo Martínez,&nbsp;E Cazorla,&nbsp;E Cánovas,&nbsp;K Anniuk,&nbsp;A E Cores,&nbsp;A M Serrano","doi":"10.2147/TACG.S239917","DOIUrl":null,"url":null,"abstract":"<p><p>The molybdenum cofactor deficiency is an autosomal recessive disease, characterized by rapidly progressive and severe neurological damage that mimics a hypoxic-ischemic encephalopathy due to the accumulation of toxic metabolites that cause rapid neurodegeneration after the delivery. It is eventually lethal, in a similar way to the rare isolated sulfite oxidase deficiency. This serious pathology usually causes death in the immediate neonatal period in the more severe variants. We report a case of two consecutive pregnancies with enlarged cisterna magna as the only prenatal pathological finding since 26 weeks of gestation (WG) and the subsequent death of the newborns in the first week after birth. After the second pregnancy, we reached the diagnosis of molybdenum cofactor deficiency due to MOCS1 gene mutation. According to the cases reported in the literature, this is the case with the earliest neuroimage prenatal findings.</p>","PeriodicalId":506374,"journal":{"name":"The Application of Clinical Genetics","volume":"13 ","pages":"49-55"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2147/TACG.S239917","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Application of Clinical Genetics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/TACG.S239917","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7

Abstract

The molybdenum cofactor deficiency is an autosomal recessive disease, characterized by rapidly progressive and severe neurological damage that mimics a hypoxic-ischemic encephalopathy due to the accumulation of toxic metabolites that cause rapid neurodegeneration after the delivery. It is eventually lethal, in a similar way to the rare isolated sulfite oxidase deficiency. This serious pathology usually causes death in the immediate neonatal period in the more severe variants. We report a case of two consecutive pregnancies with enlarged cisterna magna as the only prenatal pathological finding since 26 weeks of gestation (WG) and the subsequent death of the newborns in the first week after birth. After the second pregnancy, we reached the diagnosis of molybdenum cofactor deficiency due to MOCS1 gene mutation. According to the cases reported in the literature, this is the case with the earliest neuroimage prenatal findings.

Abstract Image

Abstract Image

Abstract Image

钼辅助因子缺乏症:连续两次妊娠大池及文献回顾。
钼辅助因子缺乏症是一种常染色体隐性遗传病,其特征是快速进展和严重的神经损伤,类似于缺氧缺血性脑病,由于有毒代谢物的积累,导致分娩后快速神经退行性变。它最终是致命的,就像罕见的孤立亚硫酸盐氧化酶缺乏症一样。这种严重的病理通常导致死亡,在新生儿期较严重的变种。我们报告一例连续两次怀孕与大池扩大作为唯一产前病理发现自妊娠26周(WG)和新生儿在出生后第一周死亡。在第二次怀孕后,由于MOCS1基因突变,我们诊断为钼辅助因子缺乏。根据文献报道的病例,这是最早的神经图像产前发现的病例。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书